{"id":"https://genegraph.clinicalgenome.org/r/3095d4ec-842c-422c-8e05-cda0df51ac62v1.0","type":"EvidenceStrengthAssertion","dc:description":"The *ITGA3* gene is located on chromosome 17 at q21.33 and encodes the protein integrin alpha 3 which dimerizes with integrin beta 1 to form the α3β1 integrin duplex that functions as an adhesion molecule between the podocyte and glomerular basement membrane. \n\n*ITGA3* was first reported in relation to autosomal recessive 'interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital' in 2012 (Has et al., PMID: 22512483, OMIM:614748). The mechanism of pathogenicity is known to be loss of function. Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital is characterized by significant protein loss in the urine, severe lung disease and/or blistering skin disease within the first months of life causing generalized edema, respiratory failure and/or skin/nail abnormalities. \n\nAt least 10 variants (frameshift, splice, missense) have been reported in 10 probands in 9 publications (PMIDs: 22512483, 23114595, 25810266, 26854491, 32198874, 34023363, 34751145, 33768705 included in this curation). More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached, considering case-level data.\n\nThis gene-disease relationship is also supported by animal models, expression studies, in vitro functional assays, and rescue assays (PMIDs: 9211352, 30466509, 9151677, 8951069, 17015618, 19118220). In particular, ITGA3 knockout mice caused congenital epidermolysis bullosa-phenotype (PMID 9211352), abnormal nephrogenesis and abnormal lung morphogenesis (PMID 30466509). Transgenic mice with ITGA3 knockout isolated to the podocyte (2.5P-Cre; ITGA3fl /fl) developed nephrotic syndrome with severe proteinuria, focal segmental glomerulosclerosis and podocyte effacement (PMID 17015618). Transgenic mice with ITGA3 knockout isolated to the skin (K14-Cre; ITGA3fl /fl) developed severe skin defects recapitulating the epidermolysis bullosa-phenotype (PMID 19118220). In-vitro functional assays demonstrated increased fibronectin expression in skin, kidney and lung cells of a patient with *ITGA3* mutation and interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital (PMID 30466509). This was associated with an increased keratinocyte migratory phenotype (also seen in the K14-Cre; ITGA3fl /fl mouse), which could be rescued using by retroviral re-expression of ITGA3 (PMID 30466509). A total of 5.5/6 pts. for experimental evidence was reached.\n\nIn summary, there is definitive evidence supporting the relationship between *ITGA3* and autosomal recessive interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/3095d4ec-842c-422c-8e05-cda0df51ac62","GCISnapshot":"https://genegraph.clinicalgenome.org/r/3dc277da-52f8-4f64-91a8-cd6c4f68db3a","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/3dc277da-52f8-4f64-91a8-cd6c4f68db3a_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10068","date":"2022-05-09T02:30:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/3dc277da-52f8-4f64-91a8-cd6c4f68db3a_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10068","date":"2024-01-09T09:23:46.326Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3dc277da-52f8-4f64-91a8-cd6c4f68db3a_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1dc64909-18d5-4ce9-9c63-a98637f6e85d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e3534747-c49b-4b6d-89e0-c9f6de05991e","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e3534747-c49b-4b6d-89e0-c9f6de05991e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26854491","allele":{"id":"https://genegraph.clinicalgenome.org/r/2a5836c6-8544-4f37-bcec-ffb4b4b3e65b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000017.11:g.50074437T>A (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573106091"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/1dc64909-18d5-4ce9-9c63-a98637f6e85d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26854491","rdfs:label":"1","ageType":"AgeAtDeath","ageUnit":"Months","ageValue":4,"allele":{"id":"https://genegraph.clinicalgenome.org/r/2a5836c6-8544-4f37-bcec-ffb4b4b3e65b"},"firstTestingMethod":"PCR","phenotypeFreeText":"ILD, renal involvement (proteinuria not reported) and macroscopically normal skin","previousTesting":false,"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/e3534747-c49b-4b6d-89e0-c9f6de05991e_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/7336f589-f2f1-4d28-b220-564dc111b67b_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9157063e-556e-4b0b-8e85-8630adb65fae","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9157063e-556e-4b0b-8e85-8630adb65fae_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Mutant protein accumulated intracellularly (colocalized with calnexin and golgin-97)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/9157063e-556e-4b0b-8e85-8630adb65fae_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25810266","allele":{"id":"https://genegraph.clinicalgenome.org/r/e787cbb0-e345-412f-8191-10745a070482","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002204.4(ITGA3):c.1387C>T (p.Arg463Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA204457"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/7336f589-f2f1-4d28-b220-564dc111b67b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25810266","rdfs:label":"A3113-21 ","ageType":"AgeAtDeath","ageUnit":"Months","ageValue":7,"allele":{"id":"https://genegraph.clinicalgenome.org/r/e787cbb0-e345-412f-8191-10745a070482"},"firstTestingMethod":"PCR","phenotypeFreeText":"ILD, nephrotic syndrome and fused renal ectopia","previousTesting":false,"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/9157063e-556e-4b0b-8e85-8630adb65fae_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/c2bd0620-5c72-4ebc-8ebc-462deada7bc4_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/11d2f70d-01b5-483e-b788-486f9982192f","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/11d2f70d-01b5-483e-b788-486f9982192f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34023363","allele":{"id":"https://genegraph.clinicalgenome.org/r/d3dbe3a1-6e70-4be0-a12f-7e57b9c98d22","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002204.4(ITGA3):c.3056T>C (p.Phe1019Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA400194681"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/c2bd0620-5c72-4ebc-8ebc-462deada7bc4","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34023363","rdfs:label":"II-1 ","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":13,"allele":{"id":"https://genegraph.clinicalgenome.org/r/d3dbe3a1-6e70-4be0-a12f-7e57b9c98d22"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"subnephrotic range proteinuria (3.2g/d) and ESKD, EB, facial dysmorphia, onycholysis since birth, loss of scalp hair and eyebrows","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/11d2f70d-01b5-483e-b788-486f9982192f_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/b5bab34e-22f8-42b7-85bd-380c2090407c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9e67944f-9eb3-416e-8ac4-0e826cb8eb31","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9e67944f-9eb3-416e-8ac4-0e826cb8eb31_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Hyper-glycosylation of α3 integrin prevented its hetero-dimerization with β1","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/9e67944f-9eb3-416e-8ac4-0e826cb8eb31_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23114595","allele":{"id":"https://genegraph.clinicalgenome.org/r/07d82fb0-b63f-4241-888c-74e73f1c42d3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002204.4(ITGA3):c.1045G>T (p.Ala349Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA400178952"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/b5bab34e-22f8-42b7-85bd-380c2090407c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23114595","rdfs:label":"II:2","ageType":"AgeAtDeath","ageUnit":"Months","ageValue":7,"allele":{"id":"https://genegraph.clinicalgenome.org/r/07d82fb0-b63f-4241-888c-74e73f1c42d3"},"firstTestingMethod":"Whole genome shotgun sequencing","phenotypeFreeText":"ILD, nephrotic syndrome, unilateral kidney hypoplasia","previousTesting":false,"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/9e67944f-9eb3-416e-8ac4-0e826cb8eb31_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/1206ff04-b425-4b3a-8585-0c8d217ce777_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f3a12863-4b1e-4d28-ae07-226ba7ebdbbe","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f3a12863-4b1e-4d28-ae07-226ba7ebdbbe_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22512483","allele":{"id":"https://genegraph.clinicalgenome.org/r/94cc8aad-886c-44e0-98f6-609cd1156a38","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002204.4(ITGA3):c.1173_1174del (p.Pro392ValfsTer2)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573106090"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/1206ff04-b425-4b3a-8585-0c8d217ce777","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22512483","rdfs:label":"1","ageType":"AgeAtDeath","ageUnit":"Months","ageValue":8,"allele":{"id":"https://genegraph.clinicalgenome.org/r/94cc8aad-886c-44e0-98f6-609cd1156a38"},"firstTestingMethod":"PCR","phenotypeFreeText":"Congenital ILNEB, ESKD, nail dystrophy","previousTesting":false,"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/f3a12863-4b1e-4d28-ae07-226ba7ebdbbe_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/221db755-6a5e-4d88-8da5-45aa0f317fe1_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c5a97133-310a-47a2-9722-724ae9925bfa","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c5a97133-310a-47a2-9722-724ae9925bfa_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22512483","allele":{"id":"https://genegraph.clinicalgenome.org/r/879f5538-e8b7-4505-b0a9-83c8825047fa","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002204.4(ITGA3):c.1883G>C (p.Arg628Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA129955"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/221db755-6a5e-4d88-8da5-45aa0f317fe1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22512483","rdfs:label":"3","ageType":"AgeAtDeath","ageUnit":"Months","ageValue":19,"allele":{"id":"https://genegraph.clinicalgenome.org/r/879f5538-e8b7-4505-b0a9-83c8825047fa"},"firstTestingMethod":"PCR","phenotypeFreeText":"Congenital ILNEB, ESKD, nail dystrophy","previousTesting":false,"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/c5a97133-310a-47a2-9722-724ae9925bfa_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/6c59d84e-2907-4c81-96ac-d9fb79a934bc_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6881a467-e467-4a64-af36-192aa06c5513","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6881a467-e467-4a64-af36-192aa06c5513_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22512483","allele":{"id":"https://genegraph.clinicalgenome.org/r/07381da3-b2de-4daf-9eea-57d9e1ca9967","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002204.4(ITGA3):c.1538-1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA400181729"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/6c59d84e-2907-4c81-96ac-d9fb79a934bc","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22512483","rdfs:label":"2","ageType":"AgeAtDeath","ageUnit":"Months","ageValue":2,"allele":{"id":"https://genegraph.clinicalgenome.org/r/07381da3-b2de-4daf-9eea-57d9e1ca9967"},"firstTestingMethod":"PCR","phenotypeFreeText":"Interstitial lung disease (ILD), nephrotic syndrome, ESKD. ","previousTesting":false,"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/6881a467-e467-4a64-af36-192aa06c5513_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/3f4c4d53-367b-433e-afcd-8ad2f05981d7_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2796c569-3733-4ce5-8dcd-64310832c21e","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2796c569-3733-4ce5-8dcd-64310832c21e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33768705","allele":{"id":"https://genegraph.clinicalgenome.org/r/e7a54b35-f0a8-4ac9-aeb4-920c35bb8a0d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000017.11:g.50076682G>A (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA400183076"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/b171105d-412b-417e-9407-8b1518091eb5","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b171105d-412b-417e-9407-8b1518091eb5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33768705","allele":{"id":"https://genegraph.clinicalgenome.org/r/0a4c5181-7e14-4fe9-a4bc-188b37fc0407","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002204.4(ITGA3):c.3021del (p.Leu1008Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573106092"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/3f4c4d53-367b-433e-afcd-8ad2f05981d7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33768705","rdfs:label":"1","ageType":"AgeAtDiagnosis","ageUnit":"Months","ageValue":3,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/e7a54b35-f0a8-4ac9-aeb4-920c35bb8a0d"},{"id":"https://genegraph.clinicalgenome.org/r/0a4c5181-7e14-4fe9-a4bc-188b37fc0407"}],"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Congenital ILD, renal dysplasia (ESKD at 3 months), EB without mucosal involvement","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/b171105d-412b-417e-9407-8b1518091eb5_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/2796c569-3733-4ce5-8dcd-64310832c21e_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/3dc277da-52f8-4f64-91a8-cd6c4f68db3a_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3dc277da-52f8-4f64-91a8-cd6c4f68db3a_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/85af4745-7d37-4c3b-bbf6-ee955e165678","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e0ac0964-cd27-4c45-b543-49adb28d32b9","type":"Finding","dc:description":"Similar model phenotype to human EB disease","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9151677","rdfs:label":"ITGA3-null mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/3864d6f4-25cc-4d11-90a6-d3ee24257191","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4efdea02-5e45-44b0-b2c9-74f97f345bb5","type":"Finding","dc:description":"Similar to skin phenotype in human disease","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19118220","rdfs:label":"K14-Cre; ITGA3fl/fl mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/20a7efda-a44c-4ead-840e-9861e5abd42a","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/886df6fa-ab51-49b7-a99b-7d1e683da9e3","type":"Finding","dc:description":"Glomeruli: reduced capillary loops and podocyte foot process effacement (latter similar to human disease). Abnormal lung morphogenesis with reduced branches of major bronchi\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8951069","rdfs:label":"ITGA3-null mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/d1b350f3-db33-4791-9113-740fd2b14460","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/19eb3d01-6e27-4038-aa19-06b014083ccb","type":"Finding","dc:description":"Similar to renal phenotype in human disease","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17015618","rdfs:label":"2.5P-Cre; ITGA3fl/fl mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/a2ac413b-d38d-488c-829a-a68111500cc1","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/79e9972a-85c6-45d7-b1af-42c8859b3c33","type":"Finding","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30466509","rdfs:label":"Migratory phenotype in vitro assay","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityPatientCellRescueCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/3dc277da-52f8-4f64-91a8-cd6c4f68db3a_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/20bc27f9-b0b7-4b13-9a12-9ae2e884a8ec","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2be97416-2b52-4a72-813f-996cf49fe18c","type":"FunctionalAlteration","dc:description":"Increased fibronectin expression in skin, kidney and lung cells of patients, which were associated with increased cell migratory phenotype. Fibronectin siRNA reduced migratory phenotype back to wild-type cells and associated with slowing of wound closure","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30466509","rdfs:label":"Cultured patient cells"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/3dc277da-52f8-4f64-91a8-cd6c4f68db3a_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e5c17577-8f93-4d8d-84e5-170c70e4eae5","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4ec71ed5-5d5b-4651-97fb-2e67cfe59c83","type":"Finding","dc:description":"Strong glomerular staining. Weak staining in the distal/collecting tubules and the media of extraglomerular vessels\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9211352","rdfs:label":"ITGA3 staining in normal kidney samples","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":5.5}],"evidenceStrength":"Definitive","sequence":7461,"specifiedBy":"GeneValidityCriteria8","strengthScore":17.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/ii2vghlbDbs","type":"GeneValidityProposition","disease":"obo:MONDO_0013881","gene":"hgnc:6139","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_3dc277da-52f8-4f64-91a8-cd6c4f68db3a-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}